Non-invasive eye scans allow doctors a zoomed-in, three-dimensional look beneath the eye's surface without causing discomfort or pain to the patient.

Bio-Rad Laboratories, Inc., a leader in life science research and clinical diagnostics products, today announced that MicroVal, the international certification organization for the validation and approval of alternative methods for…

In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (Leqembi, from Biogen) and donanemab (KisunlaTM, from Eli Lilly and Company), both based on immunotherapy (the use…

Malignant tumors remain a major threat to human health, with conventional therapies and first-generation immune checkpoint inhibitors (ICIs) facing limitations like drug resistance and low response rates.

A series of major studies has shown that finerenone preserves kidney function, reduces cardiovascular risk, and improves survival across a much broader range of patients with chronic kidney disease (CKD)…

A new study to be presented at the SLEEP 2026 annual meeting found that on evenings when adolescents used their smartphone before bedtime more than their own usual, they used…

As health agencies respond to the current Ebola outbreak in Central Africa, a UK manufacturer supplying water purification products for direct distribution in affected communities is warning that infection-control readiness…

Idiopathic inflammatory myopathies (IIM) are a heterogenous group of autoimmune conditions with substantial morbidity.

Randox Health today announces the launch of RanChip Insight 360, an advanced health intelligence programme designed to transform how individuals understand, monitor, and manage their long-term wellbeing.

Announcing a new article publication in BIO Integration. Latent tuberculosis infection (LTBI) is difficult to diagnose due to the lack of a definitive gold standard.